Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Osteosarcoma

A Preliminary Evaluation of Limb Salvage Surgery for Osteosarcoma around Knee Joint

Xing Wu, Zheng-dong Cai, [ ... ], Guang-jian Zhang

Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma

Clement Bailly, Rodolphe Leforestier, [ ... ], Caroline Bodet-Milin

Identification of Novel Candidate Oncogenes in Chromosome Region 17p11.2-p12 in Human Osteosarcoma

Joeri Both, Thijs Wu, [ ... ], Theo J. M. Hulsebos

Unveiling new disease, pathway, and gene associations via multi-scale neural network

Thomas Gaudelet, Noël Malod-Dognin, [ ... ], Nataša Pržulj

BMI1 Is Expressed in Canine Osteosarcoma and Contributes to Cell Growth and Chemotherapy Resistance

Mehdi Hayat Shahi, Daniel York, [ ... ], Robert B. Rebhun

Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma

Mingjun Guo, Chengkui Cai, [ ... ], Qingyu Fan

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models

Bérengère Gobin, Gatien Moriceau, [ ... ], Dominique Heymann

The ARF Tumor Suppressor Regulates Bone Remodeling and Osteosarcoma Development in Mice

Daniel A. Rauch, Michelle A. Hurchla, [ ... ], Katherine N. Weilbaecher

Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study

Daniela Caronia, Ana Patiño-Garcia, [ ... ], Anna Gonzalez-Neira

Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition

Lihua Peng, Dianming Jiang

Hyperoside, a Flavonoid Compound, Inhibits Proliferation and Stimulates Osteogenic Differentiation of Human Osteosarcoma Cells

Ning Zhang, Mei-Dan Ying, [ ... ], Ding-Sheng Lin

Digital Expression Profiling Identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as Potential Predictive Biomarkers for Neo-Adjuvant Chemotherapy Response in Paediatric Osteosarcoma

Jeffrey W. Martin, Susan Chilton-MacNeill, [ ... ], Maria Zielenska

Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity

Okkeun Jung, Angelene Soto, Andrew L. Wolfe, Shahana S. Mahajan

Advertisement

Create a weekly email alert for: Osteosarcoma

You can change these options by clicking profile then "Alerts and Notifications"